title: Idiopathic adult growth hormone deficiency.
abstract: GH secretion is controlled by hypothalamic as well as intrapituitary and peripheral signals, all of which converge upon the somatotroph, resulting in integrated GH synthesis and secretion. Enabling an accurate diagnosis of idiopathic adult GH deficiency (IAGHD) is challenged by the pulsatility of GH secretion, provocative test result variability, and suboptimal GH assay standardization. The spectrum between attenuated GH secretion associated with the normal aging process and with obesity and truly well-defined IAGHD is not distinct and may mislead the diagnosis. Adult-onset GHD is mainly caused by an acquired pituitary deficiency, commonly including prior head/neck irradiation, or an expanding pituitary mass causing functional somatotroph compression. To what extent rare cryptic causes account for those patients seemingly classified as IAGHD is unclear. About 15% of patients with adult GHD and receiving GH replacement in open-label surveillance studies are reported as being due to an idiopathic cause. These patients may also reflect a pool of subjects with an as yet to be determined occult defect, or those with unclear or incomplete medical histories (including forgotten past sports head injury or motor vehicle accident). Therefore, submaximal diagnostic evaluation likely leads to an inadvertent diagnosis of IAGHD. In these latter cases, adherence to rigorous biochemical diagnostic criteria and etiology exclusion may result in reclassification of a subset of these patients to a distinct known acquired etiology, or as GH-replete. Accordingly, rigorously verified IAGHD likely comprises less than 10% of adult GHD patients, an already rare disorder. Regardless of etiology, patients with adult GHD, including those with IAGHD, exhibit a well-defined clinical phenotype including increased fat mass, loss of lean muscle mass, decreased bone mass, and enhanced cardiac morbidity. Definition of unique efficacy and dosing parameters for GH replacement and resultant therapeutic efficacy markers in true IAGHD requires prospective study.
authors.affiliation: Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048, USA. melmed@csmc.edu
authors.forename: Shlomo
authors.initials: S
authors.lastname: Melmed
mesh_terms: D000328:Adult; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000172:deficiency* / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans
chemical_list: D019382:Human Growth Hormone
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3845-52
references.pmid: 11502822
references.citation: Eur J Endocrinol. 2009 Nov;161 Suppl 1:S75-83
references.pmid: 19684053
references.citation: Q J Med. 1989 Feb;70(262):145-60
references.pmid: 2594955
references.citation: Growth Horm IGF Res. 2009 Aug;19(4):320-6
references.pmid: 19467612
references.citation: J Clin Endocrinol Metab. 2007 May;92(5):1705-9
references.pmid: 17327383
references.citation: J Clin Invest. 2011 Jan;121(1):113-9
references.pmid: 21123951
references.citation: J Clin Endocrinol Metab. 2010 Aug;95(8):3684-92
references.pmid: 20484474
references.citation: J Clin Invest. 2003 Dec;112(11):1603-18
references.pmid: 14660734
references.citation: Clin Endocrinol (Oxf). 1992 Nov;37(5):387-97
references.pmid: 1486686
references.citation: Pituitary. 2011 Sep;14(3):208-16
references.pmid: 21132537
references.citation: Trends Endocrinol Metab. 2010 Mar;21(3):123-33
references.pmid: 20149677
references.citation: Eur J Endocrinol. 2011 Apr;164(4):491-7
references.pmid: 21220433
references.citation: PLoS One. 2011 Jan 19;6(1):e15767
references.pmid: 21283519
references.citation: Med J Aust. 2012 Aug 20;197(4):204-5
references.pmid: 22900859
references.citation: J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
references.pmid: 21602453
references.citation: JAMA. 2008 Jun 18;299(23):2792-4
references.pmid: 18560007
references.citation: Clin Endocrinol (Oxf). 2010 Oct;73(4):432-5
references.pmid: 20455893
references.citation: J Clin Endocrinol Metab. 2004 Feb;89(2):662-6
references.pmid: 14764778
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3397-401
references.pmid: 15240621
references.citation: Clin Endocrinol (Oxf). 1997 Apr;46(4):473-81
references.pmid: 9196611
references.citation: J Clin Invest. 2009 Nov;119(11):3189-202
references.pmid: 19884662
references.citation: J Clin Endocrinol Metab. 2011 Jan;96(1):115-21
references.pmid: 20926525
references.citation: Lancet. 2007 Apr 28;369(9571):1461-1470
references.pmid: 17467517
references.citation: Clin Endocrinol (Oxf). 1995 Jun;42(6):613-8
references.pmid: 7634502
references.citation: J Clin Endocrinol Metab. 1996 Mar;81(3):1169-72
references.pmid: 8772595
references.citation: J Clin Endocrinol Metab. 2004 Apr;89(4):1684-93
references.pmid: 15070931
references.citation: J Clin Endocrinol Metab. 2008 Nov;93(11):4254-60
references.pmid: 18765508
references.citation: Nat Rev Endocrinol. 2010 Oct;6(10):562-76
references.pmid: 20852587
references.citation: J Biol Chem. 2012 Jul 20;287(30):25454-65
references.pmid: 22669946
references.citation: JAMA. 2007 Sep 26;298(12):1429-38
references.pmid: 17895459
references.citation: Am J Med. 1986 Sep;81(3):457-62
references.pmid: 3092668
references.citation: Clin Chem. 2011 Apr;57(4):555-9
references.pmid: 21285256
references.citation: Horm Res. 2008;69(6):343-54
references.pmid: 18504393
references.citation: J Clin Invest. 1987 Feb;79(2):449-52
references.pmid: 3805277
references.citation: J Clin Endocrinol Metab. 2002 Apr;87(4):1654-9
references.pmid: 11932297
references.citation: J Clin Endocrinol Metab. 2009 Nov;94(11):4414-22
references.pmid: 19773395
references.citation: J Endocrinol. 2004 Feb;180(2):247-55
references.pmid: 14765976
references.citation: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7315-20
references.pmid: 16670201
references.citation: Horm Res. 2004;61(4):165-9
references.pmid: 14707471
references.citation: J Clin Endocrinol Metab. 2004 May;89(5):2048-56
references.pmid: 15126520
references.citation: Eur J Endocrinol. 2003 Apr;148 Suppl 2:S9-14
references.pmid: 12670295
references.citation: Ann Intern Med. 2010 May 4;152(9):568-77
references.pmid: 20439575
references.citation: Clin Endocrinol (Oxf). 1999 Jun;50(6):703-13
references.pmid: 10468941
references.citation: Mol Cell. 2006 Aug 4;23(3):365-75
references.pmid: 16885026
references.citation: J Clin Endocrinol Metab. 2013 Mar;98(3):980-8
references.pmid: 23345098
references.citation: Trends Endocrinol Metab. 2011 May;22(5):171-8
references.pmid: 21420315
references.citation: Eur J Endocrinol. 2007 Dec;157(6):695-700
references.pmid: 18057375
references.citation: Clin Endocrinol (Oxf). 2011 Sep;75(3):361-6
references.pmid: 21521324
references.citation: J Clin Endocrinol Metab. 2000 Apr;85(4):1353-61
references.pmid: 10770165
references.citation: J Clin Endocrinol Metab. 1997 Jan;82(1):82-8
references.pmid: 8989238
references.citation: J Clin Endocrinol Metab. 2009 Aug;94(8):2702-7
references.pmid: 19509104
references.citation: J Clin Endocrinol Metab. 2000 Oct;85(10):3693-9
references.pmid: 11061526
references.citation: J Clin Endocrinol Metab. 2000 May;85(5):1789-93
references.pmid: 10843153
references.citation: J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1039-44
references.pmid: 19587105
references.citation: Ann Intern Med. 2008 May 20;148(10):747-58
references.pmid: 18347346
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):2255-61
references.pmid: 21543424
references.citation: J Clin Endocrinol Metab. 2002 May;87(5):1961-4
references.pmid: 11994325
references.citation: Endocrinol Metab Clin North Am. 2007 Mar;36(1):37-55
references.pmid: 17336733
references.citation: Endocrinology. 1972 Jul;91(1):262-9
references.pmid: 4623634
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20452-7
references.pmid: 19088192
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):477-85
references.pmid: 11836272
references.citation: Ann Intern Med. 2008 Jun 3;148(11):827-31
references.pmid: 18519929
references.citation: J Clin Endocrinol Metab. 2001 Jun;86(6):2752-6
references.pmid: 11397882
references.citation: J Clin Endocrinol Metab. 2009 Feb;94(2):392-9
references.pmid: 19001512
references.citation: N Engl J Med. 1989 Dec 28;321(26):1797-803
references.pmid: 2687691
references.citation: J Clin Endocrinol Metab. 2009 Mar;94(3):809-16
references.pmid: 19088164
references.citation: Lancet. 2001 Feb 10;357(9254):425-31
references.pmid: 11273062
references.citation: Eur J Endocrinol. 2009 Nov;161 Suppl 1:S25-31
references.pmid: 19684060
references.citation: Nat Clin Pract Endocrinol Metab. 2006 Mar;2(3):119
references.pmid: 16932266
references.citation: Nat Rev Endocrinol. 2010 Sep;6(9):515-25
references.pmid: 20664532
references.citation: Endocr Rev. 1998 Dec;19(6):717-97
references.pmid: 9861545
references.citation: J Clin Endocrinol Metab. 2010 Aug;95(8):3750-7
references.pmid: 20501686
references.citation: J Clin Endocrinol Metab. 2006 Feb;91(2):477-84
references.pmid: 16332938
references.citation: J Endocrinol Invest. 2002 Apr;25(4):329-33
references.pmid: 12030603
references.citation: J Clin Endocrinol Metab. 2002 May;87(5):2067-79
references.pmid: 11994342
references.citation: Lancet. 2000 Sep 30;356(9236):1137-42
references.pmid: 11030292
references.citation: Br J Sports Med. 2007 May;41(5):335-6; discussion 336
references.pmid: 17324962
references.citation: N Engl J Med. 2006 Dec 14;355(24):2558-73
references.pmid: 17167139
references.citation: Eur J Endocrinol. 2006 Oct;155(4):559-66
references.pmid: 16990655
references.citation: Pituitary. 2008;11(2):121-8
references.pmid: 18404387
references.citation: Eur J Endocrinol. 2001 Sep;145(3):267-72
references.pmid: 11517006